When the WSJ’s Sharon Weinberger was diagnosed with a one-in-a-million cancer, she learned how hard it is to find treatment and support for a rare disease—and discovered reasons for hope.

Dow Jones - HealthFriday, September 19, 2025 at 3:00:00 PM
PositiveHealth
When the WSJ’s Sharon Weinberger was diagnosed with a one-in-a-million cancer, she learned how hard  it is to find treatment and support for a rare disease—and discovered reasons for hope.
Sharon Weinberger, an editor at the Wall Street Journal, faced a daunting diagnosis of a rare cancer that affects only one in a million people. Her journey highlights the significant challenges in finding appropriate treatment and support for rare diseases, a struggle many face but often go unheard. However, through her experience, she also discovered sources of hope and resilience, shedding light on the importance of awareness and advocacy for those battling similar conditions.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion
PositiveHealth
Roche's recent decision to acquire 89bio for up to $3.5 billion is a significant move aimed at enhancing its drug pipeline. This acquisition focuses on an experimental treatment for fatty liver disease, a condition increasingly associated with obesity. By investing in this promising therapy, Roche not only expands its portfolio but also addresses a growing health concern, potentially improving outcomes for many patients.
Latest from Health
RFK Jr.’s handpicked vaccine advisers met at the CDC and showed a desire to focus on side effects, change recommendations and abandon previous methods of examining scientific evidence
NeutralHealth
Health Secretary Robert F. Kennedy Jr. recently convened his selected vaccine advisers at the CDC, where they expressed a desire to reevaluate vaccine recommendations and focus more on potential side effects. This meeting is significant as it could lead to changes in public health policy and how vaccines are assessed, reflecting a shift in the ongoing conversation about vaccine safety and efficacy.
Kennedy’s Vaccine Panel Votes to Limit Access to Covid Shots
NegativeHealth
The recent decision by Kennedy's vaccine panel to limit access to COVID shots has raised significant concerns among public health advocates. This move could hinder efforts to achieve widespread immunity and protect vulnerable populations, especially as new variants emerge. It's crucial to understand the implications of such restrictions on public health and the ongoing fight against the pandemic.
How recent research and expanded diagnosis are changing our understanding of autism
PositiveHealth
Recent research and expanded diagnostic criteria are reshaping our understanding of autism, with experts firmly stating that there is no connection between vaccines and the condition. A significant review by HHS Secretary Robert F. Kennedy is anticipated soon, which could further clarify misconceptions and enhance public awareness. This matters because it helps to dispel myths surrounding autism, promotes informed discussions, and supports families affected by the condition.
CDC panel votes to change recommendations for COVID vaccines
NeutralHealth
A key panel from the CDC has voted to shift its recommendations regarding COVID vaccines, suggesting that the decision to get vaccinated should be left to individuals rather than being a blanket recommendation for all adults. This change could significantly impact insurance coverage and access to vaccines, making it a crucial development in public health policy.
FDA OKs New Keytruda Shot for Cancer
NegativeHealth
The FDA has approved Merck's new injected version of Keytruda, a significant cancer treatment. While this innovation promises quicker and easier administration, it raises concerns about potentially slowing the adoption of more affordable alternatives, which could lead to increased healthcare costs by billions. This development is crucial as it highlights the ongoing tension between innovation and accessibility in cancer care.
Pregnant Women Should Not Use Cannabis, New Medical Guidelines Say
NegativeHealth
New medical guidelines strongly advise against the use of cannabis during pregnancy, highlighting its association with poor birth outcomes and developmental delays in children. This is particularly concerning given that studies show a significant percentage of pregnant women, especially those aged 19 to 22, are using marijuana. Understanding these risks is crucial for expectant mothers to ensure the health and well-being of their children.